YonglinPuMD

PubMed

• 1 citations
  Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
  Alexandra E Rojek, Justin P Kline, Nicholas Feinberg, Daniel E Appelbaum, Yonglin Pu, Benjamin A Derman, Andrzej Jakubowiak, Satyajit Kosuri, Hongtao Liu, Mariam T Naw...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 1
• 1 citations
  Whole-body tumor segmentation from PET/CT images using a two-stage cascaded neural network with camouflaged object detection mechanisms.
  Jiangping He, Yangjie Zhang, Michael Wang, Kun Wang, Yan Ma, Xiaoyang Ding, Qiang Li, Yonglin Pu, Chung, M.> ;Medical Physics. 2023 Oct 1
• Developing a clinical and PET/CT volumetric prognostic index for risk assessment and management of NSCLC patients after initial therapy.
  Liu Liu, Jingmian Zhang, Mark K Ferguson, Daniel Appelbaum, James X Zhang, Yonglin Pu> ;Frontiers in Bioscience. 2022 Jan 12
• 4 citations
  Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
  Jonathan A. Trujillo, James Godfrey, Yifei Hu, Jun Huang, Sonali M. Smith, Matthew J. Frigault, Zachariah DeFilipp, Daniel Appelbaum, Yonglin Pu, Nicholas Feinberg, Th...> ;Blood. 2021 Jun 17
• 7 citations
  The Relative Importance of Clinical and Socio-demographic Variables in Prognostic Prediction in Non-Small Cell Lung Cancer: A Variable Importance Approach.
  Jiangping He, James X. Zhang, Chin-Tu Chen, Yan Ma, Raymond De Guzman, Jianfeng Meng, Yonglin Pu> ;Medical Care. 2020 May 1
• 2 citations
  Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
  Elizabeth A. Sokol, Roger Engelmann, Wenjun Kang, Navin Pinto, Adam Starkey, Hollie Lai, Helen Nadel, Barry L. Shulkin, Yonglin Pu, Daniel Appelbaum, Gregory A. Yanik,...> ;Pediatric Blood & Cancer. 2018 Dec 1
• 5 citations
  An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
  Joshua H. Finkle, Bill C. Penney, Yonglin Pu> ;Lung Cancer. 2018 Jul 20
• 12 citations
  Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging.
  Yonglin Pu, James X. Zhang, Haiyan Liu, Daniel Appelbaum, Jianfeng Meng, Bill C. Penney> ;European Journal of Nuclear Medicine and Molecular Imaging. 2018 Jun 7
• 2 citations
  An experimental rabbit model of symptomatic cerebral vasospasm with in vivo neuroimaging assessment and ex vivo histological validation
  Yunchang Mo, Luping Huang, Lin-Bi Chen, Michael C. Veronesi, Yiyi Shi, Sijia Chen, Linli Peng, Leping Zhou, Yonglin Pu, Junlu Wang> ;Experimental and Therapeutic Medicine. 2018 Mar 1
• Pilot Study of 99mTc-labeled Ethylene Dicysteine Deoxyglucose SPECT-CT Imaging in Treatment Response Evaluation in Patients with Locally Advanced Head and Neck Cancer.
  Daniel Thomas Ginat, Charles Westiin, Ryan J. Brisson, Chen-Tu Chin, Yonglin Pu, Hannah Zhang, Jonas A. De Souza> ;Cureus. 2017 Apr 11
• 9 citations
  Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer.
  Joshua H. Finkle, Stephanie Youngyoon Jo, Mark K. Ferguson, Haiyan Liu, Chenpeng Zhang, Xuee Zhu, Cindy Yuan, Yonglin Pu> ;European Journal of Nuclear Medicine and Molecular Imaging. 2017 Mar 7
• 10 citations
  Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer.
  Xuee Zhu, Chuanhong Liao, Bill C. Penney, Feng Li, Mark K. Ferguson, Cassie A. Simon, Tianming Wu, Haiyan Liu, Yonglin Pu> ;Nuclear Medicine Communications. 2017 Feb 1
• 4 citations
  Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation
  Brittany Z. Dashevsky, Chenpeng Zhang, Li Yan, Cindy Yuan, Lingyun Xiong, Yongmei Liu, Haiyan Liu, Feng-Ming Spring Kong, Yonglin Pu> ;European Journal of Hybrid Imaging. 2017 Jan 1
• 7 citations
  Evaluation of parkinsonism and striatal dopamine transporter loss in patients with spinocerebellar ataxia type 6
  Tao Xie, Daniel Appelbaum, Jacqueline Bernard, Mahesh Padmanaban, Yonglin Pu, Christopher M. Gomez> ;Journal of Neurology. 2016 Aug 20
• 9 citations
  Consistency of metabolic tumor volume of non-small-cell lung cancer primary tumor measured using 18F-FDG PET/CT at two different tracer uptake times.
  Haiping Liu, Ping Chen, Kristen Wroblewski, Peng Hou, Chenpeng Zhang, Yulei Jiang, Yonglin Pu> ;Nuclear Medicine Communications. 2015 Sep 1
• 14 citations
  Quantification of metabolic tumor activity and burden in patients with non-small-cell lung cancer: Is manual adjustment of semiautomatic gradient-based measurements ne...
  Piotr Obara, Haiping Liu, Kristen Wroblewski, Chenpeng Zhang, Peng Hou, Yulei Jiang, Ping Chen, Yonglin Pu> ;Nuclear Medicine Communications. 2015 Aug 1
• 18 citations
  A new PET/CT volumetric prognostic index for non-small cell lung cancer
  Hao Zhang, Kristen Wroblewski, Yulei Jiang, Bill C. Penney, Daniel Appelbaum, Cassie A. Simon, Ravi Salgia, Yonglin Pu> ;Lung Cancer. 2015 Jul 1
• 21 citations
  Relationship between Overall Survival of Patients with Non–Small Cell Lung Cancer and Whole-Body Metabolic Tumor Burden Seen on Postsurgical Fluorodeoxyglucose PET Images
  Chenpeng Zhang, Chuanhong Liao, Bill C. Penney, Daniel Appelbaum, Cassie A. Simon, Yonglin Pu> ;Radiology. 2015 Jan 14
• 5 citations
  Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.
  Navin Pinto, Douglas A. Cipkala, Patricia E. Ladd, Yonglin Pu, Susan L. Cohn> ;Pediatric Blood & Cancer. 2014 Jun 1
• 32 citations
  Prognostic value of metabolic tumor burden in lung cancer
  Piotr Obara, Yonglin Pu> ;Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 2013 Dec 17
• 50 citations
  Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer.
  Hao Zhang, Kristen Wroblewski, Daniel Appelbaum, Yonglin Pu> ;International Journal of Computer Assisted Radiology and Surgery. 2013 Mar 1
• 26 citations
  Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
  Hao Zhang, Kristen Wroblewski, Shengri Liao, Rony Kampalath, Bill C Penney, Yi Zhang, Yonglin Pu> ;Academic Radiology. 2013 Jan 1
• 8 citations
  Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer.
  Hao Zhang, Kristen Wroblewski, Yonglin Pu> ;Acta Radiologica. 2012 Jun 1
• 35 citations
  Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
  Shengri Liao, Bill C Penney, Kristen Wroblewski, Hao Zhang, Cassie A Simon, Rony Kampalath, Ming-Chi Shih, Naoko Shimada, Sheng Chen, Ravi Salgia, Daniel E Appelbaum, ...> ;European Journal of Nuclear Medicine and Molecular Imaging. 2012 Jan 1
• 97 citations
  Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
  Shengri Liao, Bill C. Penney, Hao Zhang, Kenji Suzuki, Yonglin Pu> ;Academic Radiology. 2012 Jan 1
• Join now to see all